Telehealth Insurance Gaps: Who Pays the Price?
New research exposes telehealth insurance gaps hitting Medicaid patients, dementia caregivers, and rehab patients hardest. Here's what the data show.
Independent · Biosignal Media
Straight reporting on telehealth access — GLP-1s, peptides, HRT, longevity and more. How to actually get treatment online, whether a provider is legit, what it costs, and what the law says.
Getting Treatment Online How online GLP-1 prescribing actually works A telehealth visit can end with a semaglutide prescription in minutes. Here's what a legitimate process looks like — and where the shortcuts should worry you. New research exposes telehealth insurance gaps hitting Medicaid patients, dementia caregivers, and rehab patients hardest. Here's what the data show.
New research exposes telehealth prescribing blind spots across opioid therapy, ketamine, peptides, and PrEP. Here's what regulators and patients need to know.
New peer-reviewed research exposes home-based care safety gaps in chemotherapy, remote monitoring, and at-home diagnostics. Here's what watchdogs found.
Medicaid telehealth gaps are cutting off undocumented, neurology, and palliative care patients. New research shows who loses access and why.
New research exposes mHealth safety gaps in cancer, dementia, and IoT care. Watchdogs must act now to protect vulnerable patients. Not medical advice.
New research on eHealth nutrition programs reveals critical gaps in equity, retention, and oversight. Here's what watchdogs and consumers need to know.
A step-by-step guide to obtaining semaglutide or tirzepatide through telehealth — eligibility, the process, what it costs, and how to avoid the traps.
Testosterone therapy is a few clicks away — but it's a controlled substance that needs bloodwork and a real evaluation. Here's the legitimate path and the red flags.